tetano
Editor, Senior Moderator
BMC Pregnancy Childbirth
. 2024 Jul 3;24(1):459.
doi: 10.1186/s12884-024-06657-y. Pregnancy outcomes in women with severe acute respiratory syndrome coronavirus 2 reinfections compared to those with a single infection: a retrospective cohort study
Yan Ma[SUP] #[/SUP][SUP] 1 [/SUP], Qingxia Zhang[SUP] #[/SUP][SUP] 2 [/SUP], Zhenli Shan[SUP] 1 [/SUP], Yanting Chen[SUP] 2 [/SUP], Yan Chen[SUP] 3 [/SUP], Xiaoyu Pan[SUP] 4 [/SUP], Yiying Huang[SUP] 5 [/SUP]
Affiliations
Background: To assess pregnancy outcomes in women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection.
Methods: This was a retrospective cohort study that included pregnant women who contracted coronavirus disease 2019 (COVID-19) once or twice during pregnancy and who gave birth between 1 October 2022 and 15 August 2023 in Shanghai First Maternity and Infant Hospital (Shanghai, China). We collected their clinical data and compared the frequency of adverse pregnancy outcomes between the reinfection group and the primary infection group, such as preterm birth, fetal growth restriction (FGR), hypertensive disorders of pregnancy (HDP), common pregnancy-related conditions, birth weight, and neonatal unit admission.
Results: We observed a 7.7% reinfection rate among the 1,405 women who contracted COVID-19 during pregnancy. There were no significant differences in the frequency of preterm birth, FGR, HDP, other common pregnancy-related conditions, birth weight, or rate of neonatal unit admission between the reinfection and single infection groups. All our participants were unvaccinated, and all had mild symptoms.
Conclusion: Our study showed no significant association between SARS-CoV-2 reinfection and adverse pregnancy outcomes.
Keywords: Coronavirus disease 2019; Gestation trimester; Pregnancy outcome; Reinfection.
. 2024 Jul 3;24(1):459.
doi: 10.1186/s12884-024-06657-y. Pregnancy outcomes in women with severe acute respiratory syndrome coronavirus 2 reinfections compared to those with a single infection: a retrospective cohort study
Yan Ma[SUP] #[/SUP][SUP] 1 [/SUP], Qingxia Zhang[SUP] #[/SUP][SUP] 2 [/SUP], Zhenli Shan[SUP] 1 [/SUP], Yanting Chen[SUP] 2 [/SUP], Yan Chen[SUP] 3 [/SUP], Xiaoyu Pan[SUP] 4 [/SUP], Yiying Huang[SUP] 5 [/SUP]
Affiliations
- PMID: 38961348
- DOI: 10.1186/s12884-024-06657-y
Background: To assess pregnancy outcomes in women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection.
Methods: This was a retrospective cohort study that included pregnant women who contracted coronavirus disease 2019 (COVID-19) once or twice during pregnancy and who gave birth between 1 October 2022 and 15 August 2023 in Shanghai First Maternity and Infant Hospital (Shanghai, China). We collected their clinical data and compared the frequency of adverse pregnancy outcomes between the reinfection group and the primary infection group, such as preterm birth, fetal growth restriction (FGR), hypertensive disorders of pregnancy (HDP), common pregnancy-related conditions, birth weight, and neonatal unit admission.
Results: We observed a 7.7% reinfection rate among the 1,405 women who contracted COVID-19 during pregnancy. There were no significant differences in the frequency of preterm birth, FGR, HDP, other common pregnancy-related conditions, birth weight, or rate of neonatal unit admission between the reinfection and single infection groups. All our participants were unvaccinated, and all had mild symptoms.
Conclusion: Our study showed no significant association between SARS-CoV-2 reinfection and adverse pregnancy outcomes.
Keywords: Coronavirus disease 2019; Gestation trimester; Pregnancy outcome; Reinfection.